CN108812538A - A kind of preparation method of the nutritional egg with sight protectio and enhancing - Google Patents
A kind of preparation method of the nutritional egg with sight protectio and enhancing Download PDFInfo
- Publication number
- CN108812538A CN108812538A CN201810639292.1A CN201810639292A CN108812538A CN 108812538 A CN108812538 A CN 108812538A CN 201810639292 A CN201810639292 A CN 201810639292A CN 108812538 A CN108812538 A CN 108812538A
- Authority
- CN
- China
- Prior art keywords
- egg
- lutein
- zeaxanthin
- dha
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 12
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 9
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 124
- 235000012680 lutein Nutrition 0.000 claims abstract description 65
- 239000001656 lutein Substances 0.000 claims abstract description 65
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 65
- 229960005375 lutein Drugs 0.000 claims abstract description 65
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 65
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 65
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 60
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 60
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 59
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 59
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 59
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 59
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 58
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 230000036541 health Effects 0.000 claims abstract description 11
- 241000233671 Schizochytrium Species 0.000 claims abstract description 10
- 230000000474 nursing effect Effects 0.000 claims abstract description 9
- 240000008042 Zea mays Species 0.000 claims abstract description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 8
- 235000019198 oils Nutrition 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 7
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 6
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 6
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 6
- 240000000785 Tagetes erecta Species 0.000 claims abstract description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 6
- 235000005822 corn Nutrition 0.000 claims abstract description 6
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 6
- 235000019733 Fish meal Nutrition 0.000 claims abstract description 5
- 235000021323 fish oil Nutrition 0.000 claims abstract description 5
- 239000004467 fishmeal Substances 0.000 claims abstract description 5
- 239000000470 constituent Substances 0.000 claims abstract description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 70
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 67
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims description 62
- 230000004438 eyesight Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 5
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 239000010977 jade Substances 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 238000003987 high-resolution gas chromatography Methods 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 3
- 235000013601 eggs Nutrition 0.000 description 47
- 239000007788 liquid Substances 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 210000001508 eye Anatomy 0.000 description 15
- 235000013305 food Nutrition 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 210000002969 egg yolk Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 10
- 210000001525 retina Anatomy 0.000 description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000003208 petroleum Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- 235000021466 carotenoid Nutrition 0.000 description 5
- 150000001747 carotenoids Chemical class 0.000 description 5
- 238000010812 external standard method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004330 Rhodopsin Human genes 0.000 description 4
- 108090000820 Rhodopsin Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 210000002189 macula lutea Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000013345 egg yolk Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- -1 β-Hu Luo Bu Su Chemical compound 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 101000823778 Homo sapiens Y-box-binding protein 2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001025261 Neoraja caerulea Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000003811 acetone extraction Methods 0.000 description 1
- QZMKHBQNIWNUPJ-UHFFFAOYSA-N acetonitrile;n,n-diethylethanamine;methanol Chemical compound OC.CC#N.CCN(CC)CC QZMKHBQNIWNUPJ-UHFFFAOYSA-N 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001748 carotenols Chemical class 0.000 description 1
- 235000005471 carotenols Nutrition 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000873 fovea centralis Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 235000021129 infant diet Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000009374 poultry farming Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004491 retinal development Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000200 toxicological information Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 125000001695 zeaxanthin group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
The present invention is a kind of preparation method of nutritional egg with sight protectio and enhancing.Step is:Laying hen several for selecting the health of laying period;In the daily feed of above-mentioned laying hen, while adding any one of each group in following three groups of constituents, first group:Lutein, marigold, other frequently seen plants rich in lutein;It is 0.0005%~0.01% that the quality of contained lutein, which accounts for the ratio of feed for nursing gross mass, in lutein quality or marigold or other plants rich in lutein;Second group:Zeaxanthin, corn, other frequently seen plants rich in zeaxanthin;It is 0.0003%~0.012% that the quality of contained zeaxanthin, which accounts for the ratio of feed for nursing gross mass, in zeaxanthin quality or corn or other plants rich in zeaxanthin;Third group:Fish meal, linseed, schizochytrium powder, schizochytrium mud, DHA fish oil, DHA algal oil, the quality of DHA contained therein are the 0.1~1.0% of feed for nursing gross mass;It is continuous to feed 1-6 weeks;Obtain egg.
Description
Technical field
The invention belongs to field of biotechnology, it is related to poultry farming, it is specifically a kind of to have effects that sight protectio and enhancing
The preparation method of nutritional egg.
Background technique
The nutriments such as necessary amino acid, fatty acid, vitamin, minerals in egg rich in needed by human body, are consumption
The daily necessity of person, while being also the good carrier of lutein, zeaxanthin and DHA.By nutrition regulation means, in egg
Lutein is added in chicken feed, and perhaps DHA etc. can produce enrichment lutein or the egg of DHA.However, not having by changing also
Become the feed ingredient that poultry is fed, produces the report containing high lutein, zeaxanthin and the egg of DHA three simultaneously.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, and for modern's work and life pressure, big, eyesight is asked
The feature that topic takes place frequently, sight protectio and enhancing are in great demand, on the nutritive value of this traditional food of egg, the present invention is logical
The feed addictive rich in lutein, zeaxanthin and DHA is crossed while adding into egg feedstuff, to produce while rich in leaf Huang
The egg of element, zeaxanthin and DHA.
To solve the above-mentioned problems, a kind of system of the nutritional egg rich in lutein, zeaxanthin and DHA simultaneously of the present invention
Preparation Method the technical solution adopted is that:
(1) laying hen several for selecting the health of laying period;
(2) in the daily feed of above-mentioned laying hen, each group in following three groups of constituents is added simultaneously according to mass percent
Any one of, first group:Lutein, marigold, other frequently seen plants rich in lutein;Second group:Zeaxanthin, jade
Rice, other frequently seen plants rich in zeaxanthin;Third group:Fish meal, linseed, schizochytrium powder, schizochytrium mud, DHA fish
Oil, DHA algal oil;It is continuous to feed 1-6 weeks;
(3) the three kinds of additives added in above-mentioned egg feedstuff, lutein quality (or marigold or other yellow rich in leaf
Element plant in contained lutein quality) account for feed for nursing gross mass ratio be 0.0005%~0.01%;Zeaxanthin
The quality quality of contained zeaxanthin (or in corn or other plants rich in zeaxanthin) accounts for feed for nursing gross mass
Ratio is 0.0003%~0.012%;Fish meal, linseed, schizochytrium powder, schizochytrium mud, DHA fish oil, institute in DHA algal oil
Quality containing DHA is the 0.1~1.0% of feed for nursing gross mass;
The egg that laying hen produces, uses the content of its Lutein of high effective liquid chromatography for measuring for 0.5~5.0mg/100g
Egg, using rp-hplc determination, wherein zeaxanthin is 0.3~6.0mg/100g egg, using efficient
The content that gas chromatography measures wherein DHA is 50~500mg/100g egg;
Lutein (Lutein, 3 ' 3- dihydroxy-alpha-carotene) is that one kind is widely present in the plant such as vegetables, flowers, fruit
Natural materials in object belong to " carotenoids class " race's substance, it is known that in nature there is more than 600 kinds of carotenoid,
In only about 20 kinds be present in the blood and tissue of people.Medical experiment proves that natural carotenol contained in plant is a kind of property
The excellent antioxidant of energy, a certain amount of lutein is added in food can prevent cell ageing and aging of body organs, simultaneously
Visual impairment caused by senile eyeball retina macular degeneration and blindness can also be prevented, pass through a series of medical research, class
Carrotene has been proposed as cancer preventive agent, life extender, ulcer resistant preparation, heart attack and coronary artery disease
Inhibitor.Especially in terms of sight protectio and enhancing, lutein has a series of function, including:For the master of retina
Pigment composition is wanted, the eyes of the mankind contain the lutein of a large amount, and this element is that human body can not manufacture, it is necessary to yellow by intake leaf
It usually supplements, if lacking this element, eyes will blind;Phototoxis is protected the eyes from, the aging of eyes is delayed and is prevented
Only lesion;Eyesight is protected, lutein can promote visual purple in retina cell as antioxidant and photoprotection
(Rhodopsin) regeneration can prevent laser high myopia and detached retina, and can promote eyesight, protection eyesight, be particularly suitable for
Student, driver et al. are edible;Alleviate visual fatigue symptom:(blurred vision, eye are dry and astringent, eye is swollen, ophthalmodynia, photophobia etc.);Improve macula lutea
Pigment density protects macula lutea, promotes macula lutea development;Prevent macular degeneration and retinal pigment degeneration etc..
Zeaxanthin (Zeaxanthin, 3,3 '-dihydroxy-beta carotene) is a kind of novel oil-soluble natural pigment,
It is widely present in green leafy vegetable, flowers, fruit, fructus lycii and yellow maize.In nature usually with lutein, β-Hu Luo
Bu Su, kryptoxanthin etc. coexist, and form carotenoid mixture.In human body, zeaxanthin be mainly distributed on eye, liver, pancreas,
In the histoorgans such as kidney, spleen, ovary, play an important role to health.In eyes, zeaxanthin is concentrated mainly on view
The macula lutea district center of film.Human body and animal itself can not synthesize zeaxanthin, it is necessary to pass through food or replenishers obtain.In human body
Interior, zeaxanthin is a kind of powerful antioxidant, can also be protected by Anti-oxidation behaviors such as quenching singlet oxygen, removing free radicals
Body tissue cell, thus protect biosystem from some since excessive oxidation reacts generated potential illeffects,
Therefore there is antitumaous effect, prevention cardiovascular disease, prevention and other effects.If the not macular area of normal function, people
Main visual function can gradually damage, or even have the danger of blindness.In macular area central point, incident light is most strong, the work of generation
Property oxygen is also most.Epidemiological studies result also indicates that there is zeaxanthin specificity absorption most to damage to retina
The effect of the blue ray of property, to protect the cone cell of fovea centralis.Many studies have shown that increasing maize in short term
Matter intake can be such that macular pigment increases, to enhance the ability of macular area confrontation harmful substance and light ray damage, prevention
With slow down senile macular degeneration.In addition, zeaxanthin itself has very high nutritive value, it can be in human liver after eating
It is converted to biologically active vitamin A, it is disease-resistant to growth and development, protection eyesight and the epithelial cell, the raising that promote human body
Ability extends the service life etc. with special effect.
DHA (Docosahexaenoic Acid, DHA, docosahexaenoic acid) is the important substance of human brain development, growth
One of, it is the important composition ingredient of brain and retina, content is up to 20% in human brain cortex, in eye retina
Proportion is maximum, accounts for about 50%.Lacking DHA intake will lead to DHA content decline in retinal tissue, and cause retina electric
Scheme not normal.In addition, DHA plays the regeneration of visual pigment rhodopsin vital, and rhodopsin is in light
It plays a crucial role in the system converted to visual pattern.Meanwhile it is newest research shows that the unsaturated fatty acids such as DHA also have drop
Health benefits in terms of the eyes such as low intraocular pressure, crystalline lens pressure and glaucoma.Some researches show that contain in infant's diet and fill
Sufficient DHA can make infant quick-eyed, and visual performance development is very fast.Since DHA concentration is relatively low in premature's body, spy is needed
Not Bu Chong DHA to guarantee the normal development of premature's optic cell.Pregnant woman is rich in the nutriment of DHA in pregnancy period intake, leads to
It crosses and is transported to fetal brain and retina, the nerve cell maturity of fetus can be made to improve.The U.S.《Clinical nutriology magazine》?
At 2002 just it is reported that, baby feed rich in DHA 52 week of food after, vision obviously than in control group not into
The healthy babies for eating DHA are sensitive.
Above-mentioned three kinds substances relevant to human body visual acuity and protection, cannot need to pass through meals synthesized by human body
Food additionally takes the intake such as capsule.Wherein, the nutrient being can absorb when lutein is mankind's daily consumption fruit and vegetables,
But absorption rate is generally lower, has been incorporated as dietary supplements early in lutein in 1996.Green pot-herb is leaf Huang
The main dietary source of element, but wherein zeaxanthin is less.The United Nations FAO/WHO, the United Nations food additives expert committee
Member can 1977 the 21st time report regulation:All to separate from known food, the unconverted pigment of chemical structure, use is dense
When degree meets the natural concentration in former food again, it is considered as food, does not need toxicological information, and zeaxanthin is known food
One of ingredient in object corn belongs to carotenoid, considers in conjunction with its physico-chemical analysis result, it is believed that it is safe and non-toxic, Ke Yizhi
It scoops out in food, medicine and cosmetic industry, maximum usage amount to be 5.0g/Kg.It is deep-sea fish, linseed, rich in micro- algae powder
Containing DHA, but it is difficult in the ordinary meal of most crowds comprising these foods, it is normal far from meeting by food intake
The demand of human body.It is suitable for intake that each crowd DHA recommends in United States Medicine research institute (IOM) daily, is -18 years old 4 years old daily respectively
90-160 milligrams, daily 160 milligrams of adult, daily 200 milligrams of pregnant woman.Egg is universal as a kind of indispensable food of high nutrition
It in people's lives, is a kind of very nutritious, relative low price common food, edible object is quite extensive, from 4
~5 months babies are until old man, is suitable for edible egg.
While the present invention is by adjusting the optimal content of lutein, zeaxanthin, DHA three in egg, it ensure that
Three together the effect of promote mutually, it is edible to safeguard eyes and nervous centralis health, be optimal to eyesight
Effect is protected and enhanced, this has far reaching significance for the eye health level for improving China resident.Meanwhile feeding the present invention specially
The feed of addition lutein, zeaxanthin and DHA, can significantly improve the immunity of laying hen, thus subtract significantly while benefit proposes
The egg nutrient equilibrium of the use of few antibiotic, output is abundant, and yolk tinctorial yield is high, and antibiotic-free residual, mouthfeel is more aromatic,
Also it is relatively beneficial to human health.
Bring benefit of the present invention is based on the following:One) lutein and zeaxanthin are only two types in eyes
Carrotene, however, ratio collocation can not in most cases be optimal, such as green leaf in the common food of intake
It is the main dietary source of lutein with vegetables, but wherein zeaxanthin is less.Two) lutein is with zeaxanthin
The patron saint of DHA, DHA and lutein and zeaxanthin can more play the role of bringing out the best in each other with benefit, and retina is rich in
DHA unsaturated fatty acid, DHA are easily oxidised, and such as lack lutein and zeaxanthin, mend DHA more again to retinal development
With health-care effect and have a greatly reduced quality, and the anti-oxidation protection effect of lutein abundant contained by macular area can allow view
Film is protected from the injury of fat oxidation, while can also prevent the generation of DHA fishlike smell.Three) some researches show that lutein, jade
Cream-coloured matter and DHA (when such as being boiled, fried to egg, decocting cooking operation), can still retain major part under certain high temperature
Activity.
Remarkable result of the present invention is, the egg rich in lutein, zeaxanthin and DHA while production, lutein, corn
Yellow matter and the collocation of the content of DHA are rationally, edible to meet the needs of human body is for lutein, zeaxanthin and DHA simultaneously, and
And play the role of effect and bring out the best in each other, can safeguard eyes and nervous centralis health, be optimal to the protection of eyesight and
Reinforcing effect.Meanwhile laying hen is raised with the method for offer of the invention, lutein, zeaxanthin and DHA in feed can not only
The nutritional ingredient of feed is protected, and the immunity of laying hen can be improved, thus greatly reduces the use of antibiotic, the egg of output
Nutrient equilibrium is abundant, and yolk tinctorial yield is high, and antibiotic-free residual, mouthfeel is more aromatic, is also relatively beneficial to human health.
Specific embodiment
Below by embodiment, invention is further described in detail.
Embodiment 1:The laying hen for choosing 60 20 week old, is randomly divided into two groups, it is desirable that the laying hen between each group grows and lays eggs
Situation no significant difference, one group of laying hen eats no added basal feed respectively during experiment, two groups of laying hens eat feed addition
0.01% lutein sterling, 0.002% zeaxanthin sterling with 2% algae oil (DHA content 40%), experimental period 42
It, daily observe laying hen growing state, situation of laying eggs, and in 42 days every group take 10 pieces of eggs to be detected.
The results show:Two groups of laying hens are without death in breeding process, and one group of laying hen dead 1, egg production and average egg
Weight is without significant difference, but the produced egg yolk Lutein of two groups of laying hens, zeaxanthin and DHA content are high (table 1), yolk color
It is deeper.
Remarkable result of the invention is, the egg rich in lutein, zeaxanthin and DHA while production, lutein, jade
Cream-coloured matter and the collocation of the amount of DHA are rationally, edible to meet the needs of human body is for lutein, zeaxanthin and DHA simultaneously, and
And play the role of effect and bring out the best in each other, can safeguard eyes and nervous centralis health, be optimal to the protection of eyesight and
Reinforcing effect.Meanwhile laying hen is raised with the method for offer of the invention, lutein, zeaxanthin and DHA in feed can not only
The nutritional ingredient of feed is protected, and the immunity of laying hen can be improved, thus greatly reduces the use of antibiotic, the egg of output
Nutrient equilibrium is abundant, and yolk tinctorial yield is high, and antibiotic-free residual, mouthfeel is more aromatic, is also relatively beneficial to human health.
Embodiment 2:Same as Example 1, only two groups of egg feedstuffs are added to 0.005% lutein sterling, 0.001%
Zeaxanthin sterling with 1% algae oil (DHA content 40%).
The results show:Two groups of laying hens are without death in breeding process, and one group of laying hen sick 1, egg production and average egg
Weight is without significant difference, but the produced egg yolk Lutein of two groups of laying hens, zeaxanthin and DHA amount are high (table 2), and yolk color is more
It is deep.
In conclusion the contents of the present invention are not limited in the above embodiments, the knowledgeable people in same area can
Can propose other embodiments easily within technological guidance's thought of the invention, but this embodiment is included in this hair
Within the scope of bright.
1. being measured using high performance liquid chromatography to the lutein content in egg
1.1 method summaries
After lutein acetone extraction in egg yolk, detected at 446nm in high performance liquid chromatograph, with external standard method
It is quantitative.
1.2 instrument
High performance liquid chromatograph, UV detector, ultrasonic extractor, eddy mixer, centrifuge, uv-spectrophotometric
Meter.
1.3 reagent
Lutein mark product:Lutein (purity > 99%, Fluka company of the U.S.).Acetone, methylene chloride, methanol (chromatography
It is pure, J.T.Baker company of the U.S.);2,6-di-tert-butyl p-cresol (BHT), methyl tertiary butyl ether(MTBE) (MTBE) (purity > 99%,
Sigma Co., USA);Egg to be measured
1.4 determination step
1.4.1 sample preparation
Raw egg takes yolk, and freeze-drying is pulverized afterwards for 24 hours.1.0g (being accurate to 0.001g) sample is accurately weighed, is used
5mL warm water sufficiently dissolves, and 10mL acetone soln (containing 0.12%BHT) and 5.0g NaCl is added, and shakes 15min, low-temperature centrifugation
5min (4000r/min), 4 DEG C), take supernatant into 10mL centrifuge tube, with acetone soln constant volume, after -40 DEG C of freezing 1h, again
(4 DEG C) centrifugation 5min of low temperature.Supernatant is taken to cross 0.22 μm of filter membrane to be analyzed.It meets light due to lutein to be extremely easy in decomposition, Gu Yangpinchu
Reason overall process should be protected from light as far as possible.
1.4.2 the preparation of lutein standard solution
1.0mg (being accurate to 0.1mg) lutein standard items are accurately weighed, 10mL is dissolved and be settled to methylene chloride, is matched
100mg/L standard reserving solution is made;Standard reserving solution accurately is pipetted, with methanol dilution, is configured to 20mg/L standard intermediate solution,
It is kept in dark place after being distributed into several bottles in -80 DEG C of refrigerators.Standard intermediate solution is taken out from -80 DEG C of refrigerators before use, is put to room
Wen Houyong acetone soln (containing 0.12% (mass fraction, similarly hereinafter) BHT) is diluted to the standard working solution of 20~500 μ g/L.
1.4.3 chromatographic condition
Chromatographic column:YMC Carotenoid C30 column (150mm × 4.6mm, 3 μm);Mobile phase:Methanol-methyl tertbutyl
Ether (70: 30, v/v), isocratic elution;Column temperature:25℃;Flow velocity:0.5mL/min;Sample volume:5μL;Detection wavelength:446nm.
1.4.4 measurement:Different standard solutions is taken respectively, is injected in high performance liquid chromatography and is separated, it is molten with standard
The retention time of liquid appearance is qualitative, records corresponding peak area, canonical plotting is drawn, with quantified by external standard method.
1.5 results calculate
X=(c*V1*100)/(m*V2*1000)
X-sample Lutein content (mg/100g) in formula
The concentration (μ g/mL) for the sample liquid Lutein that c-is looked into from mark product curve
M-sample quality (g)
E-sample constant volume (mL)
K-sample measurement liquid product (mL)
The conversion coefficient of 1000-μ g conversion mg.
The content that egg Lutein can be obtained is 0.5~5.0mg/100g egg.
2. being measured using reversed-phased high performace liquid chromatographic to the zeaxanthin in egg
2.1 method summaries
The reversed-phased high performace liquid chromatographic of zeaxanthin, using C30 column, with acetonitrile-methanol-triethylamine (75:25:
0.05, V/V) and methyl tertiary butyl ether(MTBE)-triethylamine (100:0.05, V/V) gradient elution is carried out for mobile phase, UV detector exists
It is detected at 450nm, quantified by external standard method.
2.2 instrument
High performance liquid chromatograph, UV detector, ultrasonic extractor, eddy mixer, centrifuge, uv-spectrophotometric
Meter.
2.3 reagent
Lutern (95.8%), zeaxanthin (99.8%) Sigma Co., USA;Acetonitrile, methanol, methyl tertiary butyl ether(MTBE)
Fisher company of (chromatographically pure) U.S.;Triethylamine, petroleum ether (30~60 DEG C of boiling range), dehydrated alcohol, anhydrous sodium sulfate, hydroxide
Potassium, DBPC 2,6 ditertiary butyl p cresol (BHT), ascorbic acid (being that analysis is pure) Chinese medicines group chemical reagents corporation;Water is
Milli-Q Gradient ultrapure water.
2.4 determination step
2.4.1 sample preparation
(1) it is saponified
Raw egg takes yolk, and freeze-drying is pulverized afterwards for 24 hours.It accurately weighs sample and weighs 5g, accurately to 0.0001g,
It is placed in 250mL round-bottomed flask, adds 50mL ascorbic acid ethanol solution, be completely dispersed sample with homogenizer homogeneous, be passed through nitrogen
Gas adds 10mL 500g/L potassium hydroxide solution, is uniformly mixed, and is placed in 60 DEG C of water-bath reflux 40min, oscillation prevents sample frequently
It is adhered in bottle wall, saponification terminates, and uses 5mL ethyl alcohol respectively, and 5mL water autocondensation tube top end is rinsed inside it, and it is cooling to take out flask
To about 40 DEG C.
(2) it extracts
It is quantitative to shift whole saponification liquors in the 500mL separatory funnel for filling 60mL petroleum ether, with 30~50mL distilled water
Divide 2~3 flushing round-bottomed flasks to be incorporated to separatory funnel, fierceness oscillation 2min, deflates, then mix, stratification.Shift water phase
In the 2nd separatory funnel, repeats to extract twice with 40mL petroleum ether by several times, discard water phase, merge 3 petroleum ether phases.Every time
With 60mL distillation water washing petroleum ether extract 2~3 times to neutral, gently shaking by swirling when first washing prevents from emulsifying.Petroleum ether mentions
Take liquid by anhydrous sodium sulfate be dehydrated, after be transferred in 250mL chicken heart bottle, add 100mg BHT to be allowed to dissolve.The above operation exists
It is protected from light in vent cabinet and carries out.
(3) it is concentrated
Petroleum ether extract is placed on Rotary Evaporators, it is dry in 40 DEG C of partial vacuum, bath temperature condition evaporations.Residue
It is dissolved with 2mL methanol, 0.22 μm of membrane filtration, is measured to high performance liquid chromatograph.
2.4.2 the preparation of zeaxanthin standard solution
Zeaxanthin standard reserving solution:With a small amount of acetone solution, it is respectively 100 that again with methanol, which is made into mass concentration for solvent,
μ g/mL and 40 μ g/mL standard items stock solutions.It can be diluted to series standard solution as needed.
2.4.3 chromatographic condition
Chromatographic column:Ultimate XB-C30 chromatographic column (250mm × 4.6mm, 5 μm);Flow velocity:1.0mL/min;Column temperature:25
℃;Detector:UV detector, wavelength 450nm;Sampling volume:20μL.Mobile phase A:Acetonitrile-methanol-triethylamine (75:
25:0.05, V/V), Mobile phase B:Methyl tertiary butyl ether(MTBE)-triethylamine (100:0.05, V/V).
2.4.4 measurement:Different standard solutions is taken respectively, is injected in high performance liquid chromatography and is separated, it is molten with standard
The retention time of liquid appearance is qualitative, records corresponding peak area, canonical plotting is drawn, with quantified by external standard method.
2.5 results calculate
X=(c*V1*100)/(m*V2*1000)
In formula in X-sample zeaxanthin content (mg/100g)
The concentration (μ g/mL) of c-zeaxanthin from the sample liquid that mark product curve is looked into
M-sample quality (g)
E-sample constant volume (mL)
K-sample measurement liquid product (mL)
The conversion coefficient of 1000-μ g conversion mg.
It is 0.3~6.0mg/100g egg that zeaxanthin in egg, which can be obtained,.
3. being measured using high resolution gas chromatography method to the DHA content in egg
3.1 mention oil:Raw egg takes yolk, and freeze-drying is pulverized afterwards for 24 hours.Powder sample obtained by about 25mg is weighed to be put into
15mL centrifuge tube records the weight.750 μ L chloroforms and 300 μ L ultrapure waters are added into the test tube, test tube is then placed in 37 DEG C
Lower 180rpm/min shakes 1 hour.2mL fat-extraction liquid (chloroform is added into the test tube again:Methanol=2:1, v/v, 0.1%
BHT), 180rpm/min at 37 DEG C is placed in shake 1 hour.Test tube is centrifuged 5min under 5500rpm room temperature, extracts subnatant
Body is to another clean tube.Residue is added after 2mL fat-extraction liquid is placed in 37 DEG C of 180rpm/min concussions 1 hour and 1mL is added
Ultrapure shaking water mixes, and is centrifuged 5min under 5500rpm room temperature again, extracts lower liquid and gained lower liquid is mixed for the first time
It closes.1mL KCl (1mol/L) solution is added to mixed liquid and rocks mixing, 5min is centrifuged under 5500rpm room temperature, extracts
Lower liquid is to another clean tube.1mL ultrapure water is added into gained lower liquid again, mixing is rocked, in 5500rpm room temperature
Lower centrifugation 5min extracts 1mL lower liquid to a prior weighed (m1) clean 2mL centrifuge tube in, and in traditional vacuum
It is 1 hour dry in spinner, it extracts again dried in traditional vacuum spinner in remaining lower liquid to the 2mL centrifuge tube
Night.It is weighed again (m to 2mL centrifuge tube2) obtain grease obtained weight (m2-m1)。
The measurement of 3.2 DHA contents:Grease obtained middle addition 1mL n-hexane and 10 μ L KOH-CH into above-mentioned steps3OH
(2mol/L) solution, 65 DEG C placement 4-6 hours, 12000rpm room temperature be centrifuged 30s, extract supernatant liquid body be settled to 1mL
DHA content is carried out using gas chromatograph to measure to obtain DHA sample concentration.
3.2.1 chromatographic condition
HP-5 capillary chromatographic column (30m × 0.25mm × 0.25 μm), 280 DEG C of injector temperature, hydrogen flame (FID) detection
240 DEG C of device temperature, column temperature:200 DEG C of initial temperature, 30 DEG C/min of heating rate rises to 280 DEG C of holding 5min, flow rate of carrier gas
1.0mL/min, 1.0 μ L of sample volume, split ratio 100:1.It is qualitative with retention time, peak area quantified by external standard method, in this experiment item
Under part, the retention time of DHA is 16.457min.
3.2.2 standard curve
3.2.2.1 the preparation of Standard Stock solutions
It accurately weighs DHA mark product 450mg and is diluted to graticule with n-hexane in 10mL volumetric flask, and immediately, standard is stored up at this time
The concentration of standby solution, DHA 45mg/mL.
3.2.2.2 the production of standard curve
Standard Stock solutions carbon disulfide is diluted to the standard series (unit for being configured to following mass concentration step by step:mg/
mL).DHA:5.0.0,10.0,15.0,20.0,25.0.1.0 μ L of sample introduction is in line between sample volume and peak area within this range
Sexual intercourse, standard curve are y=2E+10x-2E+06 (y is DHA peak area, and x is DHA concentration), related coefficient 0.9998.
3.3 total DHA contents calculate
It is 50-500mg/100g egg that total DHA content in egg, which can be obtained,.
Table 1:Test the egg measurement that lutein, zeaxanthin and DHA are added in a feed
Table 2:Test the egg measurement that lutein, zeaxanthin and DHA are added in two feeds
Claims (3)
1. a kind of preparation method of the nutritional egg with sight protectio and enhancing, it is characterised in that include the following steps:
One, laying hen several for selecting the health of laying period;
Two, it in the daily feed of above-mentioned laying hen, is added simultaneously according to mass percent in each group in following three groups of constituents
It is any, first group:Lutein, marigold or other frequently seen plants rich in lutein;Second group:Zeaxanthin, jade
Rice or other frequently seen plants rich in zeaxanthin;Third group:Fish meal, linseed, schizochytrium powder, schizochytrium mud, DHA
Fish oil or DHA algal oil;Continuously feed 1-6 weeks acquisition egg;
The three kinds of additives added in above-mentioned egg feedstuff, Lutein additive amount or marigold are other rich in lutein
Plant in contained lutein additive amount account for feed for nursing gross mass ratio be 0.0005%~0.01%;Zeaxanthin adds
The additive amount of contained zeaxanthin accounts for feed for nursing gross mass in dosage or corn or other plants rich in zeaxanthin
Ratio is 0.0003%~0.012%;Fish meal, linseed, schizochytrium powder, schizochytrium mud, DHA fish oil, institute in DHA algal oil
Quality containing DHA is the 0.1~1.0% of feed for nursing gross mass.
2. a kind of preparation method of nutritional egg with sight protectio and enhancing according to claim 1, special
Sign is that obtaining egg is measured the lutein in egg using high performance liquid chromatography, obtains egg and uses reversed phase high efficiency
Liquid chromatography is measured the zeaxanthin in egg, obtains egg using high resolution gas chromatography method to the DHA in egg
Content is measured.
3. a kind of nutritional egg rich in lutein, zeaxanthin and DHA simultaneously is for protecting and enhancing human body eyesight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810639292.1A CN108812538A (en) | 2018-06-20 | 2018-06-20 | A kind of preparation method of the nutritional egg with sight protectio and enhancing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810639292.1A CN108812538A (en) | 2018-06-20 | 2018-06-20 | A kind of preparation method of the nutritional egg with sight protectio and enhancing |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108812538A true CN108812538A (en) | 2018-11-16 |
Family
ID=64143110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810639292.1A Pending CN108812538A (en) | 2018-06-20 | 2018-06-20 | A kind of preparation method of the nutritional egg with sight protectio and enhancing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108812538A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111264720A (en) * | 2020-03-16 | 2020-06-12 | 林大昌 | Feed additive and feed for producing health-care eggs capable of preventing myopia and amblyopia and production method of quail health-care eggs |
CN114982876A (en) * | 2022-02-28 | 2022-09-02 | 南京乔康生物科技有限公司 | Laying hen feed capable of improving DHA content in eggs based on DHA algae powder and egg production method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1215550A (en) * | 1998-09-09 | 1999-05-05 | 郑婵颖 | Method for production of poultry egg |
WO2006031132A2 (en) * | 2004-09-13 | 2006-03-23 | Photonz Corporation Limited | Animals for conserving n-3 highly unsaturated fatty acids. |
CN102228136A (en) * | 2011-05-28 | 2011-11-02 | 马国庆 | Production method of nutritious target-functional eggs |
CN103070311A (en) * | 2013-01-11 | 2013-05-01 | 大连韩伟养鸡有限公司 | Production method of eggs rich in lutein |
CN104381653A (en) * | 2014-11-12 | 2015-03-04 | 浙江省长兴艾格生物制品有限公司 | Chicken feed and chicken breeding method |
CN105432554A (en) * | 2015-11-02 | 2016-03-30 | 蔡凤文 | Raising method for pawpaw chickens |
CN105767571A (en) * | 2016-03-03 | 2016-07-20 | 刘自忠 | Chlorella laying-chicken feed and feeding method thereof |
-
2018
- 2018-06-20 CN CN201810639292.1A patent/CN108812538A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1215550A (en) * | 1998-09-09 | 1999-05-05 | 郑婵颖 | Method for production of poultry egg |
WO2006031132A2 (en) * | 2004-09-13 | 2006-03-23 | Photonz Corporation Limited | Animals for conserving n-3 highly unsaturated fatty acids. |
CN102228136A (en) * | 2011-05-28 | 2011-11-02 | 马国庆 | Production method of nutritious target-functional eggs |
CN103070311A (en) * | 2013-01-11 | 2013-05-01 | 大连韩伟养鸡有限公司 | Production method of eggs rich in lutein |
CN104381653A (en) * | 2014-11-12 | 2015-03-04 | 浙江省长兴艾格生物制品有限公司 | Chicken feed and chicken breeding method |
CN105432554A (en) * | 2015-11-02 | 2016-03-30 | 蔡凤文 | Raising method for pawpaw chickens |
CN105767571A (en) * | 2016-03-03 | 2016-07-20 | 刘自忠 | Chlorella laying-chicken feed and feeding method thereof |
Non-Patent Citations (7)
Title |
---|
刘波 等: "气相色谱法测定奶粉中的EPA和DHA", 《中国乳品工业》 * |
杨玉林 等: "毛细管气相色谱法分析鸡蛋中DHA 、EPA 和亚麻酸的含量", 《上海预防医学杂》 * |
王丽娜 等: "超高效液相色谱法测定婴幼儿配方奶粉中的叶黄素", 《色谱》 * |
赵艳 等: "反相高效液相色谱法测定巴沙鱼中的黄体素和玉米黄质", 《食品科学》 * |
郑建仙: "《植物活性成分开发》", 30 June 2005, 中国轻工业出版社 * |
郑育龙: "《营养师话营养》", 30 June 2012, 金盾出版社 * |
黄小春 等: "用高效液相色谱法快速测定蛋黄中的叶黄素", 《饲料广角》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111264720A (en) * | 2020-03-16 | 2020-06-12 | 林大昌 | Feed additive and feed for producing health-care eggs capable of preventing myopia and amblyopia and production method of quail health-care eggs |
CN114982876A (en) * | 2022-02-28 | 2022-09-02 | 南京乔康生物科技有限公司 | Laying hen feed capable of improving DHA content in eggs based on DHA algae powder and egg production method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sousa et al. | Microalgae in novel food products | |
CN101999666B (en) | Health-care product composition for improving vision and preparation method thereof | |
JP2004002237A (en) | Anti-aging herb | |
CN105079009B (en) | Prevention and/or the composition for the treatment of cardiovascular and cerebrovascular disease | |
US20150182577A1 (en) | Composition For Improving Macular Pigment Density And Preventing Or Treating Age-Related Macular Degeneration | |
JP2007525189A (en) | Mixed zeaxanthin ester concentrates and their uses | |
JPWO2002043736A1 (en) | Whitening foods and drinks and oral whitening agents | |
CN100574772C (en) | A kind of soft capsule that contains phylloxanthin and preparation method thereof | |
CN101703559A (en) | Medicinal composition with function of relieving visual fatigue and preparation method thereof | |
Nolan et al. | Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophylls | |
JP2001200250A (en) | Antioxidant | |
CN108812538A (en) | A kind of preparation method of the nutritional egg with sight protectio and enhancing | |
US7595171B2 (en) | Ketocarotenoids from Adonis palaestina | |
CN106578139A (en) | Rapeseed oil for invigorating brain and application of rapeseed oil | |
JP2008127303A (en) | Agent for ameliorating functional disorder of exocrine gland, and food and drink for ameliorating functional disorder | |
TWI271156B (en) | Carotenoid esters | |
CN108185427A (en) | Composition for relieving asthenopia containing flake, theanine and phosphatidylserine | |
JP2005287376A (en) | Food and beverage composition for asthenopia | |
WO2014184655A1 (en) | Methods for using crustacean phospholipid-peptide-protein complexes | |
JP6366279B2 (en) | Preventive or ameliorating agent for overactive bladder | |
CN109123173A (en) | A kind of functional egg production method rich in DHA, astaxanthin and Co-Q10 | |
JP6063543B2 (en) | Preventive or ameliorating agent for overactive bladder | |
Inouye | The physiological bases for carotenoid color variation in the house finch, Carpodacus mexicanus | |
JP5897354B2 (en) | Preventive or ameliorating agent for overactive bladder | |
CN100382797C (en) | Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181116 |
|
RJ01 | Rejection of invention patent application after publication |